INVICTUS CEO DAN KRIZNIC TO PRESENT AT CANNABIS INVEST EUROPE
October 01 2018 - 9:21AM
InvestorsHub NewsWire
INVICTUS CEO DAN KRIZNIC TO
PRESENT AT CANNABIS INVEST EUROPE
Vancouver, BC
-- October 01, 2018 -- InvestorsHub NewsWire -- INVICTUS MD
STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1)
is pleased to announce that the
Company’s Chairman and CEO, Dan Kriznic, will be presenting at
Cannabis Invest, the UK and Europe’s leading cannabis investment
conference, in London on October 2, 2018, and in Geneva on October
3, 2018.
Mr. Kriznic will present at the following
events:
London
May Fair Hotel
October 2, 2018
8:10 a.m. to 8:30 a.m.
BST
|
Geneva
Mandarin Oriental Hotel
October 3, 2018
10:50 a.m. to 11:10 a.m.
CEST
|
The Cannabis Invest
conference, co-hosted by PI Financial Corp. (PI) and Bloom Point
Partners, brings together companies, policymakers, investors and
other stakeholders to support the awareness, financing and
development of the North American cannabis
industry.
Invictus has also granted 160,000 incentive
stock options to certain eligible persons of the Company. Each
stock option has an exercise price equal to today’s closing price
and is exercisable into one common share of the Company. The
options vest in tranches over the next twelve months and are
exercisable over a period of five years. The stock options were
granted subject to the terms and conditions of the Company’s Stock
Option Plan.
For
more information, please visit www.invictus-md.com.
On
Behalf of the Board,
Dan
Kriznic
Chairman and CEO
Jessica
Martin
Vice
President, Public Relations and Regulatory
Affairs
(833)
879-4363
About Invictus
Invictus is a global cannabis company offering a
selection of products under a wide range of lifestyle brands. Our
integrated sales approach is defined by five pillars of
distribution including medical, adult-use, international, Licensed
Producer to Licensed Producer and retail stores.
Invictus has partnered with business leaders to
convey our corporate vision, including KISS music legend and
business mogul Gene Simmons as our Chief Evangelist Officer, and
global branding agency Authentic Brands Group. Invictus is
expanding its cultivation footprint, with two cannabis production
facilities fully licensed under ACMPR in Canada and a third
awaiting approval, featuring 100,000 square feet of available grow
space today with 200,000 expected by January 2019 and 1 million by
end of 2020. To accommodate international sales, Invictus’
wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage Pharms”),
has designed and is currently building its Phase 3 and 4
purpose-built cultivation facilities to be European Union Good
Manufacturing Practices (“EU-GMP”) compliant. The Company will
earmark 50 per cent of production to the medical and recreational
markets, respectively. To ensure consistency in quality and supply,
Invictus maintains all aspects of the growing process through its
subsidiary, Future Harvest Development Ltd., a high-quality
Fertilizer and Nutrients manufacturer. Invictus drives sustainable
long-term shareholder value through a diversified product portfolio
with over 69 Health Canada approved strains and a multifaceted
distribution strategy including medical, recreational,
international and retail. For more information visit www.invictus-md.com.
Cautionary Note
Regarding Forward-Looking Statements: This release includes certain
statements and information that may constitute forward-looking
information within the meaning of applicable Canadian securities
laws or forward-looking statements within the meaning of the United
States Private Securities Litigation Reform Act of 1995. All
statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, timing, assumptions or expectations of future
performance, including the timing, approval and completion of the
Arrangement and related matters and the potential production
capacity of Invictus, are forward-looking statements and contain
forward-looking information. Generally, forward-looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", "would" or "occur".
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including that Invictus will be successful in reaching its
potential production capacity, its production facilities will be
completed as anticipated, regulatory approval will be granted as
anticipated, Invictus will reach full production capacity on the
timeline anticipated by the Company, and no unforeseen
construction delays will be experienced. These forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of the Company to be
materially different from those expressed or implied by such
forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the Company will not obtain the requisite
approvals to complete the Arrangement, Invictus will not be
successful in reaching its potential production capacity, its
production facilities will not be completed as anticipated, and
licenses or approvals being granted on terms or timelines that are
materially worse than expected by the Company. Although management
of the Company has attempted to identify important factors that
could cause actual results to differ materially from those
contained in forward-looking statements or forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements and forward-looking
information. Readers are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake to update any forward-looking statement,
forward-looking information or financial out-look that are
incorporated by reference herein, except in accordance with
applicable securities laws.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Apr 2023 to Apr 2024